Treating the Gene

Treating the Gene

At the end of 2016, Mark Meerschaert could barely walk: his prostate cancer had metastasized everywhere. Now, six months later, he feels great. What sparked this cautious optimism? Enter genetic tumor sequencing.

Read More

The 2016 State of Science Report is Here

Tumor-targeting CAR T cell immunotherapy finally works in solid tumors; soon to be in trials for prostate cancer

Immune cells that are genetically engineered with designer molecules to recognize and kill cancer cells may sound like an episode of science fiction, and for solid tumors, they used to be – until now.  At the...

You can almost say that prostate cancer liberated me and freed me to not put things live life as it is meant to be.

-Muhit Rahman, Survivor Muhit's story

Bill Nye at the Blue Jacket Fashion Show

Donate a Photo to Fund Prostate Cancer Research

Our research fights it. Your passion defeats it.

Prostate Cancer Foundation is Now "Curing Together"

Our mission is to cure prostate cancer once and for all, but we can’t do it alone.

Our research fights it. Your passion defeats it.

Prostate Cancer Screening and You

Nobody wants to think about cancer, especially prostate cancer. Nobody wants to get screened, and especially, nobody wants to even think about getting a rectal exam to check for prostate cancer. We get that.

Precision Screening

When Treatment Stops Working: Blame Resistance

When Treatment Stops Working:  Blame Resistance In the upside down world of prostate cancer, the good guys want to win the war and the bad guys are leading the resistance. Imagine Rick’s Café in Casablanca, except...

Genetic CounselingImmunotherapy

Take Back Your Sex Life

Surgery or radiation treatment for localized prostate cancer doesn’t mean that your sex life has to be over. But a big part of this may be up to you – and it’s not just that part....

Side Effects

African-American? What You Need to Know About Prostate Cancer

In the United States, men of African descent are more likely to develop prostate cancer than any other race or ethnicity.

African Descent

Where the Money Goes: Team Science


Accelerate Research  for the Cure

Accelerate Research for the Cure

82% of every donation funds research

Top Research Stories for 2016: #5

Identifying the new “weak spots” in the “soft underbelly” of the most aggressive forms of prostate cancer is the ultimate PCF R+D finding. In 2016, two PCF research teams of over 50 scientists studying a protein called N-Myc, found a major vulnerable new drug target.

Top Research
Empowering Researchers

PCF identifies the most promising research ideas and attracts brilliant individuals and teams of scientists, early in their careers, to PCF’s Research Enterprise. By channeling resources directly to the world’s top scientific minds, PCF is able to cut through red tape, speed scientific breakthroughs and deliver new treatments to patients.

For Researchers
Revolutionizing Research

The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $670 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.

Learn more about our foundation


PCF has helped add more than 30 promising new medicines to research pipeline

Dr. Drew Prostate Cancer Awareness PSA